SecBot SecBot
6-K ·Filed Jun 18, 2026

ICCM

IceCure Medical Ltd.
NEUTRAL
Impact 5/10
Horizonweeks Processed4mo ago SEC0001213900-26-070172
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for the resale registration statement filing (due within 10 trading days) and subsequent effectiveness; the lock-up period and 30-day/6-month restrictions on further equity sales may limit near-term dilution but the actual offering size and pricing relative to market will determine investor reaction.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
ICCM ▼ -65.43% at T+60d
NEUTRAL call -65.43% · α vs SPY -67.18% · entry $5.93 → $2.05
Entry = T+0 close
Jun 18, 2026
via day close
T+1d
+3.20%
call +3.20% · α +4.66%
$6.12
settled 4mo ago
T+5d
+0.51%
call +0.51% · α +2.57%
$5.96
settled 4mo ago
T+20d
-38.45%
call -38.45% · α -38.30%
$3.65
settled 3mo ago
T+60d
-65.43%
call -65.43% · α -67.18%
$2.05
settled 6w ago

Price Chart

Loading chart...

Executive Summary

IceCure Medical Ltd. filed a securities purchase agreement for a private placement of shares, pre-funded warrants, and Series D/E warrants at a $3.00 per-share purchase price, with A.G.P./Alliance Global Partners as placement agent. The filing includes lock-up agreements for officers and directors, and a commitment to file a resale registration statement within 10 trading days. No financial results or revenue figures are disclosed in the filing.

Key Facts

  • Securities purchase agreement dated June 17, 2026, for a private placement
  • Per Share Purchase Price set at $3.00
  • Includes Series D warrants (5-year term) and Series E warrants (1-year term) at $3.00 exercise price
  • Pre-funded warrants with nominal $0.0001 exercise price
  • Lock-up agreements for executive officers and directors
  • 30-day prohibition on subsequent equity sales after effective date
  • 6-month prohibition on variable rate transactions

Financial Impact

Undisclosed offering size; no subscription amounts or share counts specified in filing

dilutionshare count

Risk Factors

  • Dilution from warrant exercises if stock price appreciates above $3.00
  • No financial results or business update in this filing
  • Small market cap ($18M) increases volatility risk

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-070172
Document: ea029520001ex4-2.htm0001213900-26-070172
Document: ea029520001ex4-3.htm0001213900-26-070172
Document: ea029520001ex4-1.htm0001213900-26-070172
20 reports for ICCM
Performance horizon
83% Hit rate @ T+60 5 of 6 directional calls Went positive at some point 9 of 9 best @ T+60▲ +65.51%Jul 6, 2026
Filters
Rows
Reports for ICCM — sortable, filterable
TypeNow
Oct 13, 2026
14d ago
6-K
NEUTRAL ★ 3/10
$1.10awaiting T+60—$1.03 (−6.36%)
Oct 5, 2026
22d ago
6-K
NEUTRAL ★ 3/10
$1.27awaiting T+60—$1.03 (−18.90%)
Oct 5, 2026
22d ago
6-K
BEARISH ★ 6/10
$1.54awaiting T+60—$1.03 (+33.12%)
Sep 10, 2026
6w ago
6-K
BULLISH ★ 6/10
$2.14awaiting T+60—$1.03 (−51.87%)
Aug 24, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$2.27awaiting T+60—$1.03 (−54.63%)
Aug 19, 2026
9w ago
EFFECT
BEARISH ★ 6/10
$2.52awaiting T+60—$1.03 (+59.13%)
Aug 14, 2026
10w ago
6-K
NEUTRAL ★ 3/10
$2.82awaiting T+60—$1.03 (−63.48%)
Aug 12, 2026
10w ago
6-K
MIXED ★ 6/10
$3.11awaiting T+60—$1.03 (−66.83%)
Jul 6, 2026
16w ago
EFFECT
BEARISH ★ 6/10
$4.61 $1.59▲ +65.51%▲ +67.23%$1.03 (+77.66%)
Jun 26, 2026
17w ago
6-K
BEARISH ★ 6/10
$5.26 $1.95▲ +62.93%▲ +67.31%$1.03 (+80.42%)
Showing 10 of 20

US Market Status

Market Closed — Opens Thu (11h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026